Beam Therapeuticsinc Stock Price History
| BEAM Stock | USD 24.31 1.39 5.41% |
Below is the normalized historical share price chart for Beam TherapeuticsInc extending back to February 06, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Beam TherapeuticsInc stands at 24.31, as last reported on the 18th of April 2024, with the highest price reaching 26.14 and the lowest price hitting 24.14 during the day.
If you're considering investing in Beam Stock, it is important to understand the factors that can impact its price. Beam TherapeuticsInc appears to be somewhat reliable, given 3 months investment horizon. Beam TherapeuticsInc secures Sharpe Ratio (or Efficiency) of 0.0342, which signifies that the company had a 0.0342% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Beam TherapeuticsInc, which you can use to evaluate the volatility of the firm. Please makes use of Beam TherapeuticsInc's risk adjusted performance of 0.0172, and Mean Deviation of 3.79 to double-check if our risk estimates are consistent with your expectations.
At this time, Beam TherapeuticsInc's Total Stockholder Equity is very stable compared to the past year. As of the 18th of April 2024, Other Stockholder Equity is likely to grow to about 2.3 B, while Liabilities And Stockholders Equity is likely to drop about 794.1 M. . At this time, Beam TherapeuticsInc's Price Book Value Ratio is very stable compared to the past year. As of the 18th of April 2024, Price To Book Ratio is likely to grow to 2.25, while Price Earnings Ratio is likely to drop (16.64). Beam Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 6th of February 2020 | 200 Day MA 27.6303 | 50 Day MA 32.9897 | Beta 1.768 |
Beam |
Sharpe Ratio = 0.0342
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BEAM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.86 actual daily | 51 51% of assets are less volatile |
Expected Return
| 0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Beam TherapeuticsInc is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Beam TherapeuticsInc by adding it to a well-diversified portfolio.
Price Book 2.1577 | Enterprise Value Ebitda (7.03) | Price Sales 5.6059 | Shares Float 73.3 M | Wall Street Target Price 50 |
Beam TherapeuticsInc Stock Price History Chart
There are several ways to analyze Beam Stock price data. The simplest method is using a basic Beam candlestick price chart, which shows Beam TherapeuticsInc price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | February 27, 2024 | 45.07 |
| Lowest Price | January 26, 2024 | 24.29 |
Beam TherapeuticsInc April 18, 2024 Stock Price Synopsis
Various analyses of Beam TherapeuticsInc's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Beam Stock. It can be used to describe the percentage change in the price of Beam TherapeuticsInc from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Beam Stock.| Beam TherapeuticsInc Price Rate Of Daily Change | 0.95 | |
| Beam TherapeuticsInc Price Daily Balance Of Power | (0.70) | |
| Beam TherapeuticsInc Price Action Indicator | (1.53) |
Beam TherapeuticsInc April 18, 2024 Stock Price Analysis
Beam Stock Price History Data
The price series of Beam TherapeuticsInc for the period between Fri, Jan 19, 2024 and Thu, Apr 18, 2024 has a statistical range of 21.61 with a coefficient of variation of 16.92. The prices are distributed with arithmetic mean of 31.07. The median price for the last 90 days is 31.29. The company had 2:1 stock split on October 26, 1990. Beam TherapeuticsInc issued dividends on Feb 4, 2014.| Open | High | Low | Close | Volume | ||
04/18/2024 | 26.06 | 26.14 | 24.14 | 24.31 | ||
| 04/17/2024 | 26.06 | 26.14 | 24.14 | 24.31 | 1,443,197 | |
| 04/16/2024 | 25.23 | 25.90 | 24.84 | 25.70 | 1,676,103 | |
| 04/15/2024 | 26.20 | 26.42 | 25.14 | 25.70 | 2,234,271 | |
| 04/12/2024 | 26.99 | 26.99 | 25.52 | 25.93 | 1,299,267 | |
| 04/11/2024 | 27.49 | 27.52 | 26.67 | 27.27 | 1,069,247 | |
| 04/10/2024 | 27.52 | 27.69 | 26.69 | 27.06 | 3,283,699 | |
| 04/09/2024 | 28.86 | 29.34 | 28.20 | 29.32 | 776,406 | |
| 04/08/2024 | 28.36 | 28.86 | 28.01 | 28.81 | 850,406 | |
| 04/05/2024 | 28.51 | 28.74 | 28.03 | 28.20 | 1,505,909 | |
| 04/04/2024 | 29.75 | 30.12 | 28.90 | 29.03 | 944,402 | |
| 04/03/2024 | 30.18 | 30.72 | 29.59 | 29.68 | 1,164,900 | |
| 04/02/2024 | 30.65 | 31.00 | 30.00 | 30.55 | 1,896,106 | |
| 04/01/2024 | 32.90 | 32.99 | 31.61 | 32.66 | 1,016,806 | |
| 03/28/2024 | 34.08 | 34.17 | 32.92 | 33.04 | 1,328,949 | |
| 03/27/2024 | 33.56 | 34.20 | 32.80 | 33.96 | 780,496 | |
| 03/26/2024 | 34.31 | 34.68 | 33.19 | 33.22 | 578,353 | |
| 03/25/2024 | 33.67 | 34.35 | 33.35 | 33.69 | 409,126 | |
| 03/22/2024 | 34.90 | 34.99 | 33.38 | 33.63 | 689,032 | |
| 03/21/2024 | 35.51 | 36.75 | 34.50 | 34.95 | 1,154,778 | |
| 03/20/2024 | 34.53 | 35.73 | 33.77 | 34.87 | 1,063,071 | |
| 03/19/2024 | 33.85 | 35.16 | 33.37 | 34.84 | 947,464 | |
| 03/18/2024 | 35.40 | 35.72 | 34.03 | 34.07 | 930,507 | |
| 03/15/2024 | 34.04 | 35.45 | 33.50 | 35.41 | 3,022,032 | |
| 03/14/2024 | 37.06 | 37.42 | 33.85 | 34.61 | 1,791,843 | |
| 03/13/2024 | 35.60 | 37.49 | 35.00 | 37.37 | 1,053,601 | |
| 03/12/2024 | 37.23 | 37.23 | 35.33 | 35.80 | 2,016,260 | |
| 03/11/2024 | 37.10 | 38.37 | 36.33 | 36.57 | 957,714 | |
| 03/08/2024 | 37.91 | 38.99 | 36.88 | 37.53 | 734,417 | |
| 03/07/2024 | 38.43 | 39.14 | 36.78 | 36.96 | 924,624 | |
| 03/06/2024 | 39.76 | 40.09 | 37.51 | 38.28 | 795,963 | |
| 03/05/2024 | 37.13 | 38.86 | 37.10 | 38.51 | 1,056,382 | |
| 03/04/2024 | 40.48 | 40.65 | 38.03 | 38.24 | 1,060,962 | |
| 03/01/2024 | 40.01 | 41.26 | 39.11 | 39.84 | 1,503,043 | |
| 02/29/2024 | 45.00 | 45.05 | 38.92 | 39.49 | 2,390,382 | |
| 02/28/2024 | 44.85 | 45.79 | 42.65 | 43.61 | 2,291,904 | |
| 02/27/2024 | 39.75 | 49.50 | 38.52 | 45.07 | 7,423,756 | |
| 02/26/2024 | 33.85 | 36.02 | 33.78 | 35.80 | 1,476,578 | |
| 02/23/2024 | 33.36 | 34.66 | 33.28 | 33.99 | 1,008,646 | |
| 02/22/2024 | 31.84 | 33.87 | 31.40 | 33.54 | 1,224,132 | |
| 02/21/2024 | 31.22 | 32.16 | 30.68 | 31.76 | 803,189 | |
| 02/20/2024 | 32.35 | 33.14 | 31.33 | 31.80 | 869,697 | |
| 02/16/2024 | 32.40 | 33.75 | 32.26 | 32.90 | 1,429,799 | |
| 02/15/2024 | 31.91 | 34.22 | 31.70 | 33.02 | 1,863,942 | |
| 02/14/2024 | 30.84 | 31.71 | 29.75 | 31.29 | 2,597,838 | |
| 02/13/2024 | 31.15 | 31.61 | 29.52 | 29.98 | 2,194,638 | |
| 02/12/2024 | 28.75 | 33.56 | 28.75 | 33.40 | 2,546,824 | |
| 02/09/2024 | 28.45 | 29.54 | 28.03 | 29.05 | 923,900 | |
| 02/08/2024 | 27.55 | 28.45 | 27.35 | 28.11 | 744,056 | |
| 02/07/2024 | 27.76 | 27.85 | 26.84 | 27.57 | 703,698 | |
| 02/06/2024 | 25.86 | 27.96 | 25.36 | 27.88 | 1,058,121 | |
| 02/05/2024 | 25.23 | 26.06 | 24.14 | 25.93 | 1,135,216 | |
| 02/02/2024 | 25.46 | 26.28 | 24.01 | 25.92 | 1,373,646 | |
| 02/01/2024 | 24.56 | 26.78 | 24.08 | 26.43 | 1,322,167 | |
| 01/31/2024 | 25.58 | 26.03 | 24.27 | 24.40 | 1,456,844 | |
| 01/30/2024 | 28.10 | 28.10 | 25.79 | 25.84 | 1,581,883 | |
| 01/29/2024 | 26.05 | 28.50 | 24.65 | 28.29 | 2,134,379 | |
| 01/26/2024 | 25.23 | 25.59 | 24.18 | 24.29 | 838,910 | |
| 01/25/2024 | 25.06 | 25.86 | 24.77 | 24.92 | 746,776 | |
| 01/24/2024 | 25.47 | 25.70 | 24.73 | 24.76 | 952,676 | |
| 01/23/2024 | 25.25 | 25.48 | 24.32 | 25.00 | 721,188 |
About Beam TherapeuticsInc Stock history
Beam TherapeuticsInc investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Beam is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Beam TherapeuticsInc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Beam TherapeuticsInc stock prices may prove useful in developing a viable investing in Beam TherapeuticsInc
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 77.2 M | 56.2 M | |
| Net Loss | -234.2 M | -245.9 M |
Beam TherapeuticsInc Quarterly Net Working Capital |
|
Beam TherapeuticsInc Stock Technical Analysis
Beam TherapeuticsInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Beam TherapeuticsInc Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Beam TherapeuticsInc's price direction in advance. Along with the technical and fundamental analysis of Beam Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Beam to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0172 | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0045 | |||
| Treynor Ratio | 0.0167 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam TherapeuticsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Beam Stock, please use our How to Invest in Beam TherapeuticsInc guide.Note that the Beam TherapeuticsInc information on this page should be used as a complementary analysis to other Beam TherapeuticsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Beam Stock analysis
When running Beam TherapeuticsInc's price analysis, check to measure Beam TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beam TherapeuticsInc is operating at the current time. Most of Beam TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Beam TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beam TherapeuticsInc's price. Additionally, you may evaluate how the addition of Beam TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Beam TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Beam TherapeuticsInc. If investors know Beam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Beam TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.72) | Revenue Per Share 4.896 | Quarterly Revenue Growth 14.78 | Return On Assets (0.08) | Return On Equity (0.15) |
The market value of Beam TherapeuticsInc is measured differently than its book value, which is the value of Beam that is recorded on the company's balance sheet. Investors also form their own opinion of Beam TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Beam TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Beam TherapeuticsInc's market value can be influenced by many factors that don't directly affect Beam TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Beam TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Beam TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Beam TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.